{"id":"W4417013416","doi":"10.1182/blood-2025-2264","title":"Deep responses and durable outcomes in patients treated with belantamab mafodotin plus pomalidomide and dexamethasone from long-term follow-up of the Phase 3 dreamm-8 study","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Pomalidomide; Lenalidomide; Dexamethasone; Clinical endpoint; Hazard ratio; Randomization; Multiple myeloma; Intention-to-treat analysis; Randomized controlled trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002919518,0.0005247059,0.001307001,0.0002111974,0.0004786993,0.00155326,0.0006373133,0.0007525603,0.002173508],"category_scores_gemma":[0.001932455,0.0002945002,0.001843165,0.0003286294,0.0003482231,0.001116685,0.0008498224,0.002213577,0.0004731482],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006967919,"about_ca_system_score_gemma":0.0007274848,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004399209,"about_ca_topic_score_gemma":0.0008470413,"domain_scores_codex":[0.9989728,0.0004459209,0.00008968338,0.0002211314,0.0001215113,0.0001490658],"domain_scores_gemma":[0.998083,0.0002829456,0.0006893392,0.0002149771,0.0001290162,0.000600694],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.510752,0.009430105,0.3224129,0.001170651,0.008700462,0.0005659466,0.0004574067,0.003279691,0.01066668,0.0004159158,0.009942478,0.1222057],"study_design_scores_gemma":[0.1041983,0.1662672,0.6963516,0.0003918797,0.006452526,0.001700441,0.0003964204,0.003732529,0.003870428,0.001199915,0.0152795,0.0001592925],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.99068,0.00387103,0.0004064154,0.000351885,0.00009921227,0.0003503647,0.002649452,0.00003148282,0.00156003],"genre_scores_gemma":[0.992619,0.0005712367,0.0003737556,0.0005361151,0.0001205102,0.00038533,0.004596922,0.000008640498,0.0007886036],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002919518,"threshold_uncertainty_score":0.01544011,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0169290117943093,"score_gpt":0.3025473535185282,"score_spread":0.2856183417242189,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}